chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 71yo male with hx of degenerative lumber spinal stenosis, osteoporosis, hypothyroid, basal cell carcinoma of skin, DM type 2, barretts esophagus with dysplasia, HDL, renal transplant, COPD, carcinoma of lung, colon polyp, HTN had received covid vaccines on 1/7/2021 & 2/4/2021. Pt's wife informed facility patient passed away at outside hospital on 6/8/2021. No information available regarding patient's death at outside hospital. Likely not related to covid vaccines given > 120 days prior to death.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 89 yo had received covid vaccines on 1/14/21 & 2/11/21. Pt died on 6/4/2021 in his home after hx of prostate cancer & secondary malignancy of bone, Likely death is unrelated to covid vaccinations.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Condition aggravated, Granuloma annulare, Hypoglycaemia, Rash
Clinical narrative: Narrative:  PT RECEIVED PFIZER COVID 19 VACCINE ON 1/15 AND  DEVELOPED RASH WITHIN A WEEK. PER PHARMD PROGRESS NOTE  ON 1/28/21, "Overall, reports doing ok. Main complaint is a new rash that has  developed on both legs. Estimates that the overall size covers about a hands-width  on both sides. Describes tiny, "match-head size" red spots. Denies pain or itching.  Estimates that is started 5 days ago. Denies unusual bruising or bleeding. Please  note, given the timing on the development of his derm issues, beginning shortly  after his first covid vaccine, I entered a VAERS report. Granuloma annulare has been reported as a rare, but potential SE, occurring after vaccination. " 2ND  PFIZER COVID 19 GIVEN, ON 2/5/21. ON MARCH 3 1, DEMOTOLOGY  CLINIC COWLETED A BIOPSY ON RIGHT THIGH AND LEFT CHEEK  AND ON 4/13, PER DERMATOLOGY, "He was last seen in clinic on 3/31/21 at  which time a biopsy was performed consistent with GA". REPORTED SPREAD  OF RASH ALONG TORSO. BIOPSY ON CHEEK WAS CONSISTENT WITH  AK AND WAS HEALING WELL PER DERM. NO NEW BLEEDING,  NONHEALING OR TENDER LESIONS REPORTED. ON 4/22, PHARMD REPORTED PTS MAIN COMPLAINT WAS "Main conviaint remains his  ongoing rash, now characterized as disseminated granuloma annulare by derm  This is worse from his groin to knees, but also has areas on his back and abdomen.  He has been using the clobetasol, but hasn't noticed any benefit. He doesn't have  derm f/u until Aug. I instructed him to call for sooner flu in 2 weeks if no  improvement." PT WAS SEEN BY PHARMD, HYPOGLYCEMIA REPORTED  ON SEVERAL OCCASIONS HOWEVER LOOKS LIKE  HYPOGLYCEMIA/UNAWARENESS WAS AN ONGOING ISSUE FOR THIS PATIENT EVEN BEFORE VACCINE.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: Narrative:  PT RECEIVED PFIZER COVID 19 VACCINE ON 1/15 AND  DEVELOPED RASH WITHIN A WEEK. PER PHARMD PROGRESS NOTE  ON 1/28/21, "Overall, reports doing ok. Main complaint is a new rash that has  developed on both legs. Estimates that the overall size covers about a hands-width  on both sides. Describes tiny, "match-head size" red spots. Denies pain or itching.  Estimates that is started 5 days ago. Denies unusual bruising or bleeding. Please  note, given the timing on the development of his derm issues, beginning shortly  after his first covid vaccine, I entered a VAERS report. Granuloma annulare has been reported as a rare, but potential SE, occurring after vaccination. " 2ND  PFIZER COVID 19 GIVEN, ON 2/5/21. ON MARCH 3 1, DEMOTOLOGY  CLINIC COWLETED A BIOPSY ON RIGHT THIGH AND LEFT CHEEK  AND ON 4/13, PER DERMATOLOGY, "He was last seen in clinic on 3/31/21 at  which time a biopsy was performed consistent with GA". REPORTED SPREAD  OF RASH ALONG TORSO. BIOPSY ON CHEEK WAS CONSISTENT WITH  AK AND WAS HEALING WELL PER DERM. NO NEW BLEEDING,  NONHEALING OR TENDER LESIONS REPORTED. ON 4/22, PHARMD REPORTED PTS MAIN COMPLAINT WAS "Main conviaint remains his  ongoing rash, now characterized as disseminated granuloma annulare by derm  This is worse from his groin to knees, but also has areas on his back and abdomen.  He has been using the clobetasol, but hasn't noticed any benefit. He doesn't have  derm f/u until Aug. I instructed him to call for sooner flu in 2 weeks if no  improvement." PT WAS SEEN BY PHARMD, HYPOGLYCEMIA REPORTED  ON SEVERAL OCCASIONS HOWEVER LOOKS LIKE  HYPOGLYCEMIA/UNAWARENESS WAS AN ONGOING ISSUE FOR THIS PATIENT EVEN BEFORE VACCINE.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Anuria, Death, Hypophagia
Clinical narrative: Narrative: 90 yo pt had received covid vaccinations on 1/13/2021 & 2/24/2021. Pt died at home with home hospice on 5/29/2021 after decision made for comfort care only, Family did not want the patient to have any further hospitalizations, No ER visits, no IVAB, No dialysis. The agree that they want him comfortable and to pass in his home. Pt with hx of dementia, SVT,HTN,GERD, HBP, dysphagia and had stopped eating & urinating several weeks prior to death when decided to go to hospice care. Likely death is not related to covid vaccinations
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Dyspnoea, Painful respiration, SARS-CoV-2 test positive
Clinical narrative: Narrative: 72 yo male patient w/hx of Pulmonary Fibrosis, COPD, CAD, Esophageal CA w/mets to lungs presents to the ED with shortness of breath. Ongoing since seen on 6/1/21. States he can't his breath. + pain with deep respiration. Diagnosed with Covid Pneumonia, admitted to hospital for supportive treatment. Positive COVID 19 test after having completed vaccination series with Pfizer Covid-19 vaccine (#1 on 1/19/21, #2 on 2/9/21. Treated with dexamethasone and other supportive care (O2, inhalers, etc.) Patient's SOB improved, however he is near end-stage with metastatic cancer and plan is to discharge home with hospice care.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Holmes-Adie pupil, Photophobia
Clinical narrative: Narrative: Patient reported at recent PCP visit that she was diagnosed with adis pupil by eye provider. She says the problem occurred after her second COVID vaccination. Went to ER initially as advised by call center. Says was sent to eye provider and says al was ok except for 'reaction to light'. Then went to see Doctor. Says with diagnosis was advised to get eyes checked yearly-says was advised could return to normal or could remain.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Diarrhoea, Hallucination, SARS-CoV-2 test positive, Screaming
Clinical narrative: Narrative: 76 year old MALE with Parkinson Disease, DM type 2, BPG, HLD, Vit D def and neuropathy who presents from Nursing Home for evaluation of hallucinations for the last 2-3 days. M. he wakes every morning he screams because he think classmates from school are messing with him. This soon passes and he returns to his normal, per patient report. He denied having any fevers/chills/sweats, shortness of breath, cough, body aches or weakness though did mention having episodes of diarrhea lately. Tested positive for COVID-19. Patient admitted to medical ward for observation, hydration, and supportive care. Symptoms of diarrhea and hallucinations resolved. Patient discharged back to Nursing Home.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Narrative:
Age: 92.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: 91 yo patient died on 6/1/2021. Pt had received covid vaccines on 1/3/2021 & 2/10/2021. No information available on circumstances of pt's death. Likely not related to the vaccinations given pt's age and long time frame between date of death & vaccination dates,
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Multimorbidity
Clinical narrative: Narrative: 72yo male with history of prostate cancer, HTN, HLD, chronic Afib, CVA in 6/2016, EtOH use disorder and liver cirrhosis decompensated by ascites, squamous cell carcinoma on cheek, and lung adenocarcinoma. Died on 06/19/21 at home. Patient was administered covid vaccinations on 03/15/21 and 04/12/21. Appears patient died due to complications of his numerous disease states and death is not related to the covid vaccinations.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Disease complication
Clinical narrative: Narrative: 65yo male with a history of SCC of the anus, left tonsil SCC, and lung SCC s/p chemoradiation c/b recurrent pneumothorax, COPD, CAD, HFrEF (LVEF 45%), T2DM,HTN, HLD, and chronic anemia. Died on 06/12/21 at a long term care facility. Patient was administered covid vaccinations on 01/29/21 and 03/01/21. Appears patient died due to complications of cancer and is not related to the covid vaccinations.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 72 yo male with a history of Afib,Type 2 DM for 10+ years, CAD S/p ACS, h/o NSTEMI in 2012 and DES/PCI in 06/2011, HTN, HLD and PAF. Covid vaccinations were administered on 3/8/21 and 4/5/21. Unable to assess if death was related to covid vaccinations. No information available about patients death.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 69yo male with history of paroxysmal Afib, coronary arteriosclerosis s/p CABG, ischemic cardiomyopathy, HTN, GERD, and sleep apnea. Patient was administered covid vaccinations on 04/12/21 and 05/10/21. Patient died at an outside hospital and there is no information available about the patients death. Unable to assess if death was related to covid vaccinations.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Candida infection, Hypophagia, Magnetic resonance imaging head abnormal, Mental status changes, Pituitary enlargement
Clinical narrative: Narrative: presented to the ED on 4/30 for decreased PO intake for 2 days and altered mental status. He was recently discharged on 4/28 from hospital and treated for an aspiration pneumonia, thrush, and a UTI. On admission, pt was found to have thrush on admission and was started on IV fluconazole. His mental status initially improved on the IV fluconazole but it was transitioned to nystatin PO due to prolonged QTc. His mental status has waxed and waned. Neurology and psychiatry were consulted to assist with work- up. Neurology ordered a STAT Brain MRI due to sudden change in mental status on 5/7 from Ox2 to nonverbal and non following commands. It revealed abnormal signal around the third ventricle and mammilary bodies concerning for alcoholic encephalopathy and some fullness of his pituitary gland. he was not known to a be a heavy drinker
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia aspiration, Speech disorder, Unresponsive to stimuli, Urinary tract infection
Clinical narrative: Narrative: presented to the ED on 4/30 for decreased PO intake for 2 days and altered mental status. He was recently discharged on 4/28 from hospital and treated for an aspiration pneumonia, thrush, and a UTI. On admission, pt was found to have thrush on admission and was started on IV fluconazole. His mental status initially improved on the IV fluconazole but it was transitioned to nystatin PO due to prolonged QTc. His mental status has waxed and waned. Neurology and psychiatry were consulted to assist with work- up. Neurology ordered a STAT Brain MRI due to sudden change in mental status on 5/7 from Ox2 to nonverbal and non following commands. It revealed abnormal signal around the third ventricle and mammilary bodies concerning for alcoholic encephalopathy and some fullness of his pituitary gland. he was not known to a be a heavy drinker
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hypoxia, Multiple organ dysfunction syndrome, Pneumonia
Clinical narrative: Narrative: admitted for pneumonia and hypoxia; died from multiorgan failure; h/o alzheimers
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Pharyngeal swelling, Respiratory distress
Clinical narrative: Narrative: 37 yof sent from vaccine clinic for throat swelling and cough shortly after 1st vaccine (second dose) administration. Epi-pen administered. PT brought back to ED for Immediate tx. received 2 doses of epi for resp  distress/chest tightness, no intubation needed.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, COVID-19, Lymphocyte count decreased, Respiratory viral panel
Clinical narrative: Narrative: This is a VACCINE FAILURE. Patient received 2 doses of Pfizer covid-19 vaccine, in march and april of 2021, and then was admitted with COVID-19 positive PCR test on 6/21/21.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vaccination failure, White blood cell count decreased
Clinical narrative: Narrative: This is a VACCINE FAILURE. Patient received 2 doses of Pfizer covid-19 vaccine, in march and april of 2021, and then was admitted with COVID-19 positive PCR test on 6/21/21.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Death, Disease complication, Tracheal cancer
Clinical narrative: Narrative: 61yo male with a history of squamous cell carcinoma of trachea, malignant tumor of trachea, congestive heart failure, esophagitis, HLD, schizophrenia, alcohol abuse, elevated liver enzymes, elevated PSA, and HTN. Patient died on 06/16/2021 in hospice. Patient received one dose of the covid vaccination on 03/23/2021. Appears patient died due to complications of the malignant tumor of the trachea and death is not related to the covid vaccinations.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Amyotrophic lateral sclerosis, Condition aggravated, Death, Disease complication
Clinical narrative: Narrative: 78yo male with history of ALS - Amyotrophic lateral sclerosis, dysphagia, essential hypertension, acquired dysarthria, malnutrition, HLD, sleep apnea, and placement of gastrotomy tube. Died on 06/17/2021. Patient was administered covid vaccinations on 01/29/2021 and 02/19/2021 at an outside facility. Appears patient died due to complications of ALS and death is not related to the covid vaccinations.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Dysphagia, Dyspnoea, Oropharyngeal pain, Throat clearing
Clinical narrative: Narrative:  Patient received his first COVID-19 vaccination on 4/20/2021 and received his second COVID-19 vaccination on 5/18/2021. On 5/20/2021, patient called the telephone care service with the following complaints: sore throat rated as bad, difficulty swallowing and clearing throat. During the call, patient denied symptoms of itching, rash, hives, facial lip or tongue swelling, chest pain and dizziness. Patient attributed breathing difficulties to his COPD diagnosis and denied to get emergent help. On 5/21/2021, patient received a called from the nurse for symptoms follow-up. During the call, patient stated "I'm ok" and reported mild swelling in arm from vaccination otherwise has no complaints.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Narrative:  Patient received his first COVID-19 vaccination on 4/20/2021 and received his second COVID-19 vaccination on 5/18/2021. On 5/20/2021, patient called the telephone care service with the following complaints: sore throat rated as bad, difficulty swallowing and clearing throat. During the call, patient denied symptoms of itching, rash, hives, facial lip or tongue swelling, chest pain and dizziness. Patient attributed breathing difficulties to his COPD diagnosis and denied to get emergent help. On 5/21/2021, patient received a called from the nurse for symptoms follow-up. During the call, patient stated "I'm ok" and reported mild swelling in arm from vaccination otherwise has no complaints.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Chills, Dyspnoea, Pain
Clinical narrative: Narrative: Patient had a previous COVID-19 positive test on 3/19/2021. Patient received his first COVID-19 vaccination dose on 5/21/2021. One day post-vaccination (5/22/2021), patient reported shakes and chills. On 5/24/2021, patient reported he no longer had fevers or body aches but endorsed shortness of breath with occasional wheezing and chest tightness in addition to 6/10 injection site tenderness. Patient denied facial lip or tongue swelling. Patient seen in the emergency room and tested positive for COVID-19 on 5/24/2021; however, test result may likely be residual from prior COVID-19 test given first vaccination was given within 90 days of prior infection.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Tremor, Wheezing
Clinical narrative: Narrative: Patient had a previous COVID-19 positive test on 3/19/2021. Patient received his first COVID-19 vaccination dose on 5/21/2021. One day post-vaccination (5/22/2021), patient reported shakes and chills. On 5/24/2021, patient reported he no longer had fevers or body aches but endorsed shortness of breath with occasional wheezing and chest tightness in addition to 6/10 injection site tenderness. Patient denied facial lip or tongue swelling. Patient seen in the emergency room and tested positive for COVID-19 on 5/24/2021; however, test result may likely be residual from prior COVID-19 test given first vaccination was given within 90 days of prior infection.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Faeces discoloured, Headache, Pyrexia, Rash
Clinical narrative: Narrative:  On 4/30/2021 patient received his first dose of COVID-19 vaccination. On 5/4/2021, patient contacted telephone care service and reported the following symptoms: headache, fever, rash, and black-colored diarrhea. Patient was scheduled for primary care visit for follow-up but was rescheduled. Second dose received on 5/28/2021 with no reported side effects.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthma, Bronchitis, Chills, Condition aggravated, Depressed mood
Clinical narrative: Narrative: 66 year old male with PMH significant for asthma, allergic rhinitis, hx of migraines, T2DM with neuropathy, sleep apnea, obesity, Barrett's esophagus, PTSD, insomnia. Received COVID-19 vaccine on 2/10/21. At pharmacy  phone appointment on 2/18/21 he stated he was "feeling sick" after vaccine and was instructed to call telephone nurse extension. Called facility on 2/23/21 with complaints of productive cough with green mucus, sneezing, headache, chills and malaise. Denied runny nose, loss of taste/smell, facial/lip/tongue swelling or hives. Stated that he had an episode of diarrhea "right after" vaccine but none since. Repoted temp of 98.0F. Denied exposure to COVID-19 positive individuals in past 2 weeks. Provider discussed isolation/quarantine, fluids, OTC meds, salt water gargle, and he was instructed to get a COVID test same day. 2/23/21 COVID test results negative; Temp 98.1, RR 16, SPO2 99%, HR 92. F/u mental health appointment he stated he had been feeling depressed since vaccine due to stress and feeling nervous about second dose and experiencing similar side effects. Unclear if pt took OTC medications/nonpharmacological therapy for treatment. Symptoms appeared to have resolved by 3/10/21 pharmacy diabetes f/u appointment as he stated he was feeling well. He received his second COVID19 vaccine dose on 3/10/21. Called Facility on 3/17/21 with complaints of muscle aches, wheezing and productive cough with white-green sputum starting 4 days prior and diarrhea for 2 days. Denied fever, chest pain, difficulty breathing, loss of smell/taste. Azithromycin, guaifenesin/dextromethorphan ordered for acute bronchitis/asthma exacerbation as well as methyl salicylate for muscle aches and pt instructed to use acetaminophen PRN, albuterol PRN, and lidocaine patches. At f/u PC telephone appointment on 4/13/21 pt stated that productive cough went away with antibiotics, but was returning with mild congestion. Treated for cough/PND/allergic rhinitis/asthma with continuation of antitussive PRN, albuterol PRN, and addition of singulair. At mental health appointment on 6/17/21 he stated that he still felt as if he had residual symptoms, though unclear as to which specific symptoms. Presented at PC clinic appointment on 7/19/21 with reports of on/off cough due to asthma and green sputum for past 2 weeks which he was prescribed empiric azithromycin for asthma/allergic rhinitis. Temp 98.6, HR 90, RR 20, BP 157/89. No notable symptoms on f/u notes to date.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea paroxysmal nocturnal, Headache, Immediate post-injection reaction, Malaise
Clinical narrative: Narrative: 66 year old male with PMH significant for asthma, allergic rhinitis, hx of migraines, T2DM with neuropathy, sleep apnea, obesity, Barrett's esophagus, PTSD, insomnia. Received COVID-19 vaccine on 2/10/21. At pharmacy  phone appointment on 2/18/21 he stated he was "feeling sick" after vaccine and was instructed to call telephone nurse extension. Called facility on 2/23/21 with complaints of productive cough with green mucus, sneezing, headache, chills and malaise. Denied runny nose, loss of taste/smell, facial/lip/tongue swelling or hives. Stated that he had an episode of diarrhea "right after" vaccine but none since. Repoted temp of 98.0F. Denied exposure to COVID-19 positive individuals in past 2 weeks. Provider discussed isolation/quarantine, fluids, OTC meds, salt water gargle, and he was instructed to get a COVID test same day. 2/23/21 COVID test results negative; Temp 98.1, RR 16, SPO2 99%, HR 92. F/u mental health appointment he stated he had been feeling depressed since vaccine due to stress and feeling nervous about second dose and experiencing similar side effects. Unclear if pt took OTC medications/nonpharmacological therapy for treatment. Symptoms appeared to have resolved by 3/10/21 pharmacy diabetes f/u appointment as he stated he was feeling well. He received his second COVID19 vaccine dose on 3/10/21. Called Facility on 3/17/21 with complaints of muscle aches, wheezing and productive cough with white-green sputum starting 4 days prior and diarrhea for 2 days. Denied fever, chest pain, difficulty breathing, loss of smell/taste. Azithromycin, guaifenesin/dextromethorphan ordered for acute bronchitis/asthma exacerbation as well as methyl salicylate for muscle aches and pt instructed to use acetaminophen PRN, albuterol PRN, and lidocaine patches. At f/u PC telephone appointment on 4/13/21 pt stated that productive cough went away with antibiotics, but was returning with mild congestion. Treated for cough/PND/allergic rhinitis/asthma with continuation of antitussive PRN, albuterol PRN, and addition of singulair. At mental health appointment on 6/17/21 he stated that he still felt as if he had residual symptoms, though unclear as to which specific symptoms. Presented at PC clinic appointment on 7/19/21 with reports of on/off cough due to asthma and green sputum for past 2 weeks which he was prescribed empiric azithromycin for asthma/allergic rhinitis. Temp 98.6, HR 90, RR 20, BP 157/89. No notable symptoms on f/u notes to date.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nervousness, Productive cough, Respiratory tract congestion, Rhinitis allergic
Clinical narrative: Narrative: 66 year old male with PMH significant for asthma, allergic rhinitis, hx of migraines, T2DM with neuropathy, sleep apnea, obesity, Barrett's esophagus, PTSD, insomnia. Received COVID-19 vaccine on 2/10/21. At pharmacy  phone appointment on 2/18/21 he stated he was "feeling sick" after vaccine and was instructed to call telephone nurse extension. Called facility on 2/23/21 with complaints of productive cough with green mucus, sneezing, headache, chills and malaise. Denied runny nose, loss of taste/smell, facial/lip/tongue swelling or hives. Stated that he had an episode of diarrhea "right after" vaccine but none since. Repoted temp of 98.0F. Denied exposure to COVID-19 positive individuals in past 2 weeks. Provider discussed isolation/quarantine, fluids, OTC meds, salt water gargle, and he was instructed to get a COVID test same day. 2/23/21 COVID test results negative; Temp 98.1, RR 16, SPO2 99%, HR 92. F/u mental health appointment he stated he had been feeling depressed since vaccine due to stress and feeling nervous about second dose and experiencing similar side effects. Unclear if pt took OTC medications/nonpharmacological therapy for treatment. Symptoms appeared to have resolved by 3/10/21 pharmacy diabetes f/u appointment as he stated he was feeling well. He received his second COVID19 vaccine dose on 3/10/21. Called Facility on 3/17/21 with complaints of muscle aches, wheezing and productive cough with white-green sputum starting 4 days prior and diarrhea for 2 days. Denied fever, chest pain, difficulty breathing, loss of smell/taste. Azithromycin, guaifenesin/dextromethorphan ordered for acute bronchitis/asthma exacerbation as well as methyl salicylate for muscle aches and pt instructed to use acetaminophen PRN, albuterol PRN, and lidocaine patches. At f/u PC telephone appointment on 4/13/21 pt stated that productive cough went away with antibiotics, but was returning with mild congestion. Treated for cough/PND/allergic rhinitis/asthma with continuation of antitussive PRN, albuterol PRN, and addition of singulair. At mental health appointment on 6/17/21 he stated that he still felt as if he had residual symptoms, though unclear as to which specific symptoms. Presented at PC clinic appointment on 7/19/21 with reports of on/off cough due to asthma and green sputum for past 2 weeks which he was prescribed empiric azithromycin for asthma/allergic rhinitis. Temp 98.6, HR 90, RR 20, BP 157/89. No notable symptoms on f/u notes to date.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Secretion discharge, Sneezing, Sputum discoloured, Stress
Clinical narrative: Narrative: 66 year old male with PMH significant for asthma, allergic rhinitis, hx of migraines, T2DM with neuropathy, sleep apnea, obesity, Barrett's esophagus, PTSD, insomnia. Received COVID-19 vaccine on 2/10/21. At pharmacy  phone appointment on 2/18/21 he stated he was "feeling sick" after vaccine and was instructed to call telephone nurse extension. Called facility on 2/23/21 with complaints of productive cough with green mucus, sneezing, headache, chills and malaise. Denied runny nose, loss of taste/smell, facial/lip/tongue swelling or hives. Stated that he had an episode of diarrhea "right after" vaccine but none since. Repoted temp of 98.0F. Denied exposure to COVID-19 positive individuals in past 2 weeks. Provider discussed isolation/quarantine, fluids, OTC meds, salt water gargle, and he was instructed to get a COVID test same day. 2/23/21 COVID test results negative; Temp 98.1, RR 16, SPO2 99%, HR 92. F/u mental health appointment he stated he had been feeling depressed since vaccine due to stress and feeling nervous about second dose and experiencing similar side effects. Unclear if pt took OTC medications/nonpharmacological therapy for treatment. Symptoms appeared to have resolved by 3/10/21 pharmacy diabetes f/u appointment as he stated he was feeling well. He received his second COVID19 vaccine dose on 3/10/21. Called Facility on 3/17/21 with complaints of muscle aches, wheezing and productive cough with white-green sputum starting 4 days prior and diarrhea for 2 days. Denied fever, chest pain, difficulty breathing, loss of smell/taste. Azithromycin, guaifenesin/dextromethorphan ordered for acute bronchitis/asthma exacerbation as well as methyl salicylate for muscle aches and pt instructed to use acetaminophen PRN, albuterol PRN, and lidocaine patches. At f/u PC telephone appointment on 4/13/21 pt stated that productive cough went away with antibiotics, but was returning with mild congestion. Treated for cough/PND/allergic rhinitis/asthma with continuation of antitussive PRN, albuterol PRN, and addition of singulair. At mental health appointment on 6/17/21 he stated that he still felt as if he had residual symptoms, though unclear as to which specific symptoms. Presented at PC clinic appointment on 7/19/21 with reports of on/off cough due to asthma and green sputum for past 2 weeks which he was prescribed empiric azithromycin for asthma/allergic rhinitis. Temp 98.6, HR 90, RR 20, BP 157/89. No notable symptoms on f/u notes to date.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Narrative: 66 year old male with PMH significant for asthma, allergic rhinitis, hx of migraines, T2DM with neuropathy, sleep apnea, obesity, Barrett's esophagus, PTSD, insomnia. Received COVID-19 vaccine on 2/10/21. At pharmacy  phone appointment on 2/18/21 he stated he was "feeling sick" after vaccine and was instructed to call telephone nurse extension. Called facility on 2/23/21 with complaints of productive cough with green mucus, sneezing, headache, chills and malaise. Denied runny nose, loss of taste/smell, facial/lip/tongue swelling or hives. Stated that he had an episode of diarrhea "right after" vaccine but none since. Repoted temp of 98.0F. Denied exposure to COVID-19 positive individuals in past 2 weeks. Provider discussed isolation/quarantine, fluids, OTC meds, salt water gargle, and he was instructed to get a COVID test same day. 2/23/21 COVID test results negative; Temp 98.1, RR 16, SPO2 99%, HR 92. F/u mental health appointment he stated he had been feeling depressed since vaccine due to stress and feeling nervous about second dose and experiencing similar side effects. Unclear if pt took OTC medications/nonpharmacological therapy for treatment. Symptoms appeared to have resolved by 3/10/21 pharmacy diabetes f/u appointment as he stated he was feeling well. He received his second COVID19 vaccine dose on 3/10/21. Called Facility on 3/17/21 with complaints of muscle aches, wheezing and productive cough with white-green sputum starting 4 days prior and diarrhea for 2 days. Denied fever, chest pain, difficulty breathing, loss of smell/taste. Azithromycin, guaifenesin/dextromethorphan ordered for acute bronchitis/asthma exacerbation as well as methyl salicylate for muscle aches and pt instructed to use acetaminophen PRN, albuterol PRN, and lidocaine patches. At f/u PC telephone appointment on 4/13/21 pt stated that productive cough went away with antibiotics, but was returning with mild congestion. Treated for cough/PND/allergic rhinitis/asthma with continuation of antitussive PRN, albuterol PRN, and addition of singulair. At mental health appointment on 6/17/21 he stated that he still felt as if he had residual symptoms, though unclear as to which specific symptoms. Presented at PC clinic appointment on 7/19/21 with reports of on/off cough due to asthma and green sputum for past 2 weeks which he was prescribed empiric azithromycin for asthma/allergic rhinitis. Temp 98.6, HR 90, RR 20, BP 157/89. No notable symptoms on f/u notes to date.
Age: 5.58
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Dyspnoea, Headache, Paraesthesia oral
Clinical narrative: Narrative: Veteran received Covid-19 vaccine 3/8/2021. He called VA on 3/9/2021 reporting that he had chills, headache. and temperature of 102f after taking acetaminophen (dose unknown) an hour prior. He also stated that he had tingling in lips and increasing difficulty breathing. Denied itching. rash, nausea, vomiting, or diarrhea. Instructed to report to emergency department, though no documentation of follow up. It should be noted, veteran received second dose of Moderna Covid-19 vaccine on 11/3/2021. NO documentation of slide effects or reactions noted at this time.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness
Clinical narrative: Narrative: 68 year old male with PMH of GAD, HTN, CAD, depression,  vascular dementia, COPD, HLD, and other comorbidities reported to his PCP that he diarrhea that occurred for 6 hours starting 3 hours after receiving his 3rd dose of the Pfizer COVID-19 vaccine on 10/09/21. Later in the evening, he woke up with dizziness, BP was normal.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Alanine aminotransferase increased, Aspartate aminotransferase increased, Atrial fibrillation
Clinical narrative: Narrative:  Patient admitted to hospital for confusion. Found to be COVID-19 positive despite full Moderna COVID-19 vaccine series including third dose (vaccine dates = 1/20/21, 2/17/21, 9/1/21). Principle diagnosis = atrial fibrillation (new onset), acute metabolic encephalopathy, acute hypoxic respiratory failure, COVID-19 pneumonia in vaccinated patient. In regards to COVID-19, oxygen therapy was rapidly weaned and patient did not receive therapy at our site. Received one dose of dexamethasone and remdesivir at outside facility prior to admission to our site. Admission appears to be primarily related to confusion and management of new onset atrial fibrillation. He was also found to have orthostatic hypotension and AKI. Hospital stay extended by inability to contact family. Unclear if patient would have been admitted for COVID-19 alone as other factors contributed to hospital stay. Discharged to home alert and oriented, ambulating independently.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase increased, Blood bilirubin normal, Blood chloride normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Narrative:  Patient admitted to hospital for confusion. Found to be COVID-19 positive despite full Moderna COVID-19 vaccine series including third dose (vaccine dates = 1/20/21, 2/17/21, 9/1/21). Principle diagnosis = atrial fibrillation (new onset), acute metabolic encephalopathy, acute hypoxic respiratory failure, COVID-19 pneumonia in vaccinated patient. In regards to COVID-19, oxygen therapy was rapidly weaned and patient did not receive therapy at our site. Received one dose of dexamethasone and remdesivir at outside facility prior to admission to our site. Admission appears to be primarily related to confusion and management of new onset atrial fibrillation. He was also found to have orthostatic hypotension and AKI. Hospital stay extended by inability to contact family. Unclear if patient would have been admitted for COVID-19 alone as other factors contributed to hospital stay. Discharged to home alert and oriented, ambulating independently.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone decreased, Blood urea nitrogen/creatinine ratio, COVID-19, COVID-19 pneumonia, Carbon dioxide normal
Clinical narrative: Narrative:  Patient admitted to hospital for confusion. Found to be COVID-19 positive despite full Moderna COVID-19 vaccine series including third dose (vaccine dates = 1/20/21, 2/17/21, 9/1/21). Principle diagnosis = atrial fibrillation (new onset), acute metabolic encephalopathy, acute hypoxic respiratory failure, COVID-19 pneumonia in vaccinated patient. In regards to COVID-19, oxygen therapy was rapidly weaned and patient did not receive therapy at our site. Received one dose of dexamethasone and remdesivir at outside facility prior to admission to our site. Admission appears to be primarily related to confusion and management of new onset atrial fibrillation. He was also found to have orthostatic hypotension and AKI. Hospital stay extended by inability to contact family. Unclear if patient would have been admitted for COVID-19 alone as other factors contributed to hospital stay. Discharged to home alert and oriented, ambulating independently.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic lymphocytic leukaemia, Confusional state, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Narrative:  Patient admitted to hospital for confusion. Found to be COVID-19 positive despite full Moderna COVID-19 vaccine series including third dose (vaccine dates = 1/20/21, 2/17/21, 9/1/21). Principle diagnosis = atrial fibrillation (new onset), acute metabolic encephalopathy, acute hypoxic respiratory failure, COVID-19 pneumonia in vaccinated patient. In regards to COVID-19, oxygen therapy was rapidly weaned and patient did not receive therapy at our site. Received one dose of dexamethasone and remdesivir at outside facility prior to admission to our site. Admission appears to be primarily related to confusion and management of new onset atrial fibrillation. He was also found to have orthostatic hypotension and AKI. Hospital stay extended by inability to contact family. Unclear if patient would have been admitted for COVID-19 alone as other factors contributed to hospital stay. Discharged to home alert and oriented, ambulating independently.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic encephalopathy, N-terminal prohormone brain natriuretic peptide increased, Orthostatic hypotension, SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: Narrative:  Patient admitted to hospital for confusion. Found to be COVID-19 positive despite full Moderna COVID-19 vaccine series including third dose (vaccine dates = 1/20/21, 2/17/21, 9/1/21). Principle diagnosis = atrial fibrillation (new onset), acute metabolic encephalopathy, acute hypoxic respiratory failure, COVID-19 pneumonia in vaccinated patient. In regards to COVID-19, oxygen therapy was rapidly weaned and patient did not receive therapy at our site. Received one dose of dexamethasone and remdesivir at outside facility prior to admission to our site. Admission appears to be primarily related to confusion and management of new onset atrial fibrillation. He was also found to have orthostatic hypotension and AKI. Hospital stay extended by inability to contact family. Unclear if patient would have been admitted for COVID-19 alone as other factors contributed to hospital stay. Discharged to home alert and oriented, ambulating independently.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Injection site erythema, Injection site pruritus
Clinical narrative: Arthralgia, Diarrhea,  redness and itching at injection site
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Headache, Myalgia, Diarrhea, NauseaVomiting, etreme tiredness Narrative:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache, Myalgia, Diarrhea, NauseaVomiting, etreme tiredness Narrative:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anion gap, Arterial catheterisation, Asthenia, Atrial fibrillation
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Band neutrophil count, Blood bicarbonate decreased, Blood bilirubin increased, Blood culture, Blood gases abnormal
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood magnesium, Blood pH increased, Blood urea increased, C-reactive protein increased
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.